Cytosorbents (CTSO) Inventory Average (2011 - 2026)

Cytosorbents has reported Inventory Average for 15 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 69.73% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 69.73% YoY), and the FY2025 full-year result was $4.0 million, up 31.19% from the prior year.
• Inventory Average for Q1 2026 stood at $4.9 million, up from $4.6 million in the prior quarter.
• The five-year high for Inventory Average was $5.2 million in Q2 2022, with the low at $1.9 million in Q2 2023.
• Historically, Inventory Average has averaged $3.7 million across 5 years, with a median of $3.6 million in 2024.
• Annual changes were most pronounced in 2023 — Inventory Average plunged 63.82% — and 2024, when it surged 113.58%.
• Cytosorbents' Inventory Average stood at $3.5 million in 2022, then decreased by 9.28% to $3.2 million in 2023, then declined by 5.86% to $3.0 million in 2024, then jumped by 55.21% to $4.6 million in 2025, then increased by 5.16% to $4.9 million in 2026.
• The last three Inventory Average figures came in at $4.9 million (Q1 2026), $4.6 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.